Executive Director, Analytical Development

Company Background

The mission of Neurogene is to treat devastating neurological diseases to improve the lives of patients and families impacted by these rare diseases. Neurogene is developing novel approaches and treatments to address the limitations of conventional gene therapy in central nervous system disorders. This includes selecting a delivery approach to maximize distribution to target tissues and designing products to maximize potency and purity for an optimized efficacy and safety profile.

The Company’s novel and proprietary EXACT transgene regulation platform technology allows for the delivery of therapeutic levels while limiting transgene toxicity associated with conventional gene therapy. Neurogene has constructed a state-of-the-art gene therapy manufacturing facility in Houston, Texas. CGMP production of NGN-401 was conducted in this facility and will support pivotal clinical development activities. This transformative work is driven by our highly collaborative people who come together each day to bring us closer to achieving our mission.

As an employee of Neurogene, you will be part of building a culture that honors patient and caregiver mindsets and nurtures innovation, creative problem solving and a strong sense of purpose.

Neurogene is seeking an established leader for our Houston based Analytical development team. The successful candidate will support and guide the Analytical development team on day-to-day activities as well as Phase 2/3 or registration-stage AAV gene therapy programs.

• Provide analytical development leadership for late stage (Phase 2/3 and registration stage) AAV gene therapy programs, ensuring readiness for pivotal trials, licensure, and commercialization.
• Establish and maintain analytical control strategies, including specification setting, method lifecycle management, and continued process verification.
• Lead comparability strategy development and execution to support manufacturing changes, scale up, technology transfer, and site changes.
• Serve as the primary analytical development partner to Regulatory Affairs, supporting IND amendments, BLA submissions, health authority interactions, and regulatory inspections.
• Oversee assay validation, reference standard qualification, and transfer of analytical methods into commercial Quality Control laboratories, ensuring inspection ready execution.
• Establish analytical methods to identify, measure, characterize, and track critical product quality attributes across the pipeline.
• Develop and implement cGMP-suitable analytical methods for product characterization, in-process monitoring, development, and stability testing.
• Manage technology transfers from academic institutions and CROs as new programs come online, followed by transfer to Quality Control.
• Plan, resource, and manage all analytical development activities in collaboration with Process Development.
• Serve as an analytical development SME to interact with commercial development and other stakeholders; communicate direction and progress effectively.
• Hire, train, supervise, and develop direct reports; encourage continuing education and professional development.
• Manage shifting priorities and deliver results in a fast-paced, dynamic environment requiring strong cross-functional communication.

• Education: Ph.D. in Biochemistry, Cell Biology, or related scientific discipline.
• Experience: Minimum of 10 years of relevant experience with at least 5 years of management experience, preferably in biotechnology or gene therapy development.
• Licenses or
  
  Certifications:
  
  Ph.D. in a related field.

• Strong working knowledge of global cGMP regulations and regulatory expectations for biologics and gene therapy.
• Demonstrated expertise in analytical method development including but not limited to potency assays.
• Strong problem-solving ability, communication skills, and leadership capabilities and team leading.
• Proven experience establishing comparability strategies and analytical control programs to support process changes, scale-up, and PPQ.
• Direct experience authoring,…